There is a possibility that BNC2 may act as a tumour suppressor in the cancer cells in which it is expressed (decreasing motility for example), but the presence of high levels of BNC2 in tumour bulk sequencing could still be indicative of fibroblast infiltration and thus, poorer outcomes. Here, BNC2 is linked to neoplasm.